What Makes Charles River Laboratories (CRL) an Investment Bet?
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Charles River Laboratories International Inc. (CRL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ariel Investments John W. Rogers | 1,490,098 | $233,140,733 | +6% | 2.49% |
| 2. | Harris Associates Natixis Global Asset Management | 1,473,084 | $230,478,723 | +27% | 0.37% |
| 3. | D E Shaw D. E. Shaw | 959,537 | $150,129,159 | +59% | 0.08% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 769,437 | $120,386,113 | +33% | 0.08% |
| 5. | Millennium Management Israel Englander | 465,098 | $72,769,233 | -9% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.01 | 6,075 | $1,002,435.75 | 183,639 | 2025-02-20 | Filing | |
| $164.63 | 1,514 | $249,249.82 | 55,058 | 2025-02-20 | Filing | |
| $187.82 | 1,322 | $248,298.04 | 44,449 | 2023-11-20 | Filing | |
| $178.05 | 5,620 | $1,000,641.00 | 202,643 | 2023-11-14 | Filing | |
| $198.79 | 1,000 | $198,786.00 | 1,000 | 2023-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $157.60 | 800 | $126,080.00 | 24,116 | 2025-08-18 | Filing | |
| $150.04 | 400 | $60,016.00 | 24,916 | 2025-08-07 | Filing | |
| $139.05 | 24 | $3,337.20 | 5,575 | 2025-05-15 | Filing | |
| $137.68 | 81 | $11,152.08 | 5,599 | 2025-05-15 | Filing | |
| $136.32 | 35 | $4,771.20 | 5,680 | 2025-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,839,743 | $913,686,190 | 0.01% | |
| 2. | 3,856,066 | $603,320,130 | 0.01% | |
| 3. | 3,190,467 | $499,180,467 | 0.09% | |
| 4. | 2,177,941 | $371,295,382 | 0.6% | |
| 5. | 1,831,153 | $286,502,198 | 0.01% |
News See All
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2025 Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2025 Earnings Call Transcript November 5, 2025Charles River Laboratories International, Inc. beats earnings expectations.
Here’s Why ClearBridge Investments Growth Strategy Closed Out Charles River Laboratories International (CRL)
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2025 Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2025 Earnings Call Transcript August 6, 2025Charles River Laboratories International, Inc. misses on earnings expectations.
Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Polen U.S SMID Company Growth Strategy Sold Charles River Laboratories International (CRL) for More Attractive Opportunities
Polen Capital, an investment management company, released its “Polen US SMID Company Growth Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Charles River Laboratories International, Inc. (CRL): A Bull Case Theory
We came across a bullish thesis on Charles River Laboratories International, Inc. (CRL) on scuttleblurb’s Substack. In this article, we will summarize the bulls’ thesis on CRL.
Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT
On May 23, Redburn Atlantic turned bullish on Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2025 Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2025 Earnings Call Transcript May 7, 2025Charles River Laboratories International, Inc. beats earnings expectations.
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs...
Hedge Fund Resource Center Billionaire Hedge Funds
